News for Healthier Living

Drug Candidate Successfully Treats Atherosclerosis, Fatty Liver Disease in Large Mammals

A drug candidate previously successful at treating severe fatty liver disease, reduces atherosclerosis in large mammals, a study suggests. The compound, DT-109, presents as a dual-action drug capable of treating both metabolic dysfunction-associated steatotic liver disease (MASH) and the vascular complications associated with atherosclerosis, a significant advancement in the treatment landscape.

April 22, 2025


July 29 2025

July 28 2025

July 26 2025

July 25 2025

July 24 2025

July 23 2025

July 22 2025

July 21 2025

July 20 2025

July 19 2025

July 18 2025

July 17 2025

July 16 2025

July 15 2025